Titrate: Increase by roughly 50 mcg every one to two weeks as tolerated
A 42-year-old female with longstanding profound fatigue, chronic pain, asthma, multiple food intolerances, GI symptoms including diarrhea, urticaria, food cravings, weight gain, and migraine who was essentially housebound due to constant exhaustion (she estimated 30% of normal energy) took tirzepitide at 3.75 mg principally to address obesity
It sells for far less on Cubans Cost Plus site
Pharmaceutical companies use many computer simulations to predict, for example, how much semaglutide will be present in the blood at different dosages or through different methods of administration
Current NICE guidance on the management of obesity does not address retatrutide, as it has no UK marketing authorisation
Blood work can reveal hidden imbalances that need targeted treatment